Article
Prostate cancer risk and ESR1 TA, ESR2 CA repeat polymorphisms.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Nov 2007
McIntyre Matthew H, Kantoff Philip W, Stampfer Meir J, Mucci Lorelei A, Parslow Diane, Li Haojie, Gaziano J Michael, Abe Miyako, Ma Jing
Abstract excerpt
BACKGROUND: Experimental evidence has suggested that estrogen receptor alpha (coded by the gene ESR1) might increase prostate cancer risk, whereas estrogen receptor beta (coded by the gene ESR2) might reduce prostate cancer risk. METHODS: We investigated the relationship with prostate cancer risk of both a TA repeat polymorphism in the ESR1 5' region, ESR1 (TA)(n), and with a CA repeat polymorphism in intron 5 of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
